Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / VPT:CC - Ventripoint Announces Appointment of Chief Finance Officer


VPT:CC - Ventripoint Announces Appointment of Chief Finance Officer

(TheNewswire)

Toronto, Ontario - TheNewswire - October 3, 2023 - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV:VPT ) ( OTC:VPTDF) is pleased to announce theappointment of Mr. Jimmy Jeon as Chief Financial Officer (“CFO”)of the Company. Mr. Jeon replaces Mr. Victor Hugo, who has served asCFO since June 2020. The Company wishes to thank Mr. Hugo forfulfilling that role and to express its appreciation for hisservice.

Mr. Jeon currently works as a Senior FinancialAnalysist at Marrelli Support Services Inc. where he provides CFO,accounting, regulatory compliance, and management advisory services tonumerous public trading companies on the TSX, TSX Venture Exchange andother Canadian and U.S. exchanges. Mr. Jeon is a CPA and holds aBachelor of Business Administration and Graduate Diploma in Accountingfrom Wilfrid Laurier University.  Mr. Jeon has over 6 years’experience in various sectors, with responsibility for accounting,budgeting, financial reporting and disclosures.

About Ventripoint Diagnostics Ltd.

Ventripoint has become an industry leader in theapplication of AI (Artificial Intelligence) to echocardiography.Ventripoint's VMS products are powered by its proprietary KBRtechnology, which is the result of a decade of development andprovides accurate volumetric cardiac measurements equivalent to MRI.This affordable, gold-standard alternative allows cardiologistsgreater confidence in the management of their patients. Providingbetter care to patients serves as a springboard and basic standard forall of Ventripoint's products that guide our future developments. Inaddition, VMS+ is versatile and can be used with all ultrasoundsystems from any vendor supported by regulatory market approvals inthe U.S., Europe and Canada.

For further information, please contact:

Jonathan Robinson

JRobinson@oakhillfinancial.ca

(416)-669-1001

Dr. Alvira Macanovic

President & CEO

amacanovic@ventripoint.com

(416) 848-4156

Neither the TSX Venture Exchange nor its Regulation ServicesProvider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of thisrelease.

Copyright (c) 2023 TheNewswire - All rights reserved.

Stock Information

Company Name: Ventripoint Diagnostics Ltd.
Stock Symbol: VPT:CC
Market: TSXVC
Website: ventripoint.com

Menu

VPT:CC VPT:CC Quote VPT:CC Short VPT:CC News VPT:CC Articles VPT:CC Message Board
Get VPT:CC Alerts

News, Short Squeeze, Breakout and More Instantly...